finasteride/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Increases total testosterone
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“Before intervention, PSA and serum steroid hormone levels were not statistically different between groups; after intervention, the finasteride group had significantly lower PSA (3.2 ng/mL versus 5.2 ng/mL; P < 0.001) and DHT levels (10 ng/dL versus 27 ng/dL; P < 0.001) and a significantly higher testosterone level (382 ng/dL versus 327 ng/dL; P = 0.04) than the placebo group.”
Quoted verbatim from Tissue Effects in a Randomized Controlled Trial of Short-term Finasteride in Early Prostate Cancer.. - Study
- RCT
- Dose
- 5 mg daily
- Population
- Men with clinically organ-confined prostate cancer (Gleason score 6 or 7) randomized to finasteride or placebo for 4-6 weeks before prostatectomy
Tissue Effects in a Randomized Controlled Trial of Short-term Finasteride in Early Prostate Cancer.2016PMID:27322462Permalink
Keep reading
- Everything the graph holds on finasteride
- Every compound studied against Total testosterone
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M45HEE34VZ981Y329244H6K9